Literature DB >> 26472122

Novel X-Ray Imaging Technology Allows Substantial Patient Radiation Reduction without Image Quality Impairment in Repetitive Transarterial Chemoembolization for Hepatocellular Carcinoma.

Xiaofei Wen1, Xianxian Jiang2, Renfei Li1, Junya Zhang1, Po Yang1, Baozhong Shen3.   

Abstract

RATIONALE AND
OBJECTIVES: To assess patient radiation dose reduction and the image quality of a new X-ray imaging technology during repetitive transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC).
METHODS: Fifty HCC patients (36 men; 57 ± 11 years) undergoing repetitive TACE were first randomly assigned to receive a TACE treatment on a reference X-ray system or a low-dose system with advanced real-time image processing. The alternate system was used for a repeated TACE (treatment interval, 0.5-6 months). Fluoroscopy time, number of digital subtraction angiography (DSA), air kerma (AK), and dose area product (DAP) were compared between the two systems and between the two repetitive TACE. Three interventional radiologists independently rated the image quality in blinded offline readings.
RESULTS: Fluoroscopy time (8.7 ± 5.9 minutes vs. 8.7 ± 7.9 minutes, P = .981), numbers of DSA runs (6 ± 4 vs. 6 ± 4, P = .735), and exposure images (173 ± 86 vs. 168 ± 91, P = .916) were equivalent between the two systems. No statistical difference in X-ray usage was found between repeated treatments. Compared to the reference system, the technology significantly reduced AK and DAP by 48.6% (0.17 ± 0.13 Gy vs. 0.41 ± 0.36 Gy, P < .0001) and 50.3% (77.3 ± 55.2 Gy cm(2) vs. 195.0 ± 155.5 Gy cm(2), P < .0001), respectively. Image quality was rated comparable between the new system and the reference, with average scores of 3.9 ± 0.3 versus 4.4 ± 0.3 in fluoroscopy and 4.5 ± 0.2 versus 4.3 ± 0.3 in DSA.
CONCLUSIONS: Patient radiation exposure can be substantially reduced by a factor of approximately two with the novel X-ray imaging technology while maintaining image quality.
Copyright © 2015. Published by Elsevier Inc.

Entities:  

Keywords:  Angiography; hepatocellular carcinoma; patient radiation; radiation reduction; transarterial chemoembolization

Mesh:

Year:  2015        PMID: 26472122     DOI: 10.1016/j.acra.2015.07.010

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  1 in total

1.  Transcatheter arterial chemoembolization combined with simultaneous cone beam computed tomography-guided multipolar microwave ablation for massive hepatocellular carcinoma (≥10 cm): Safety and primary clinical results.

Authors:  Xiongying Jiang; Xue Han; Tianqi Zhang; Zhimei Huang; Jingxian Shen; Yajun Bo; Guiqun Chen; Minshan Chen; Jinhua Huang
Journal:  J Interv Med       Date:  2019-09-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.